Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

organon llc - montelukast sodium (unii: u1o3j18sfl) (montelukast - unii:mhm278sd3e) - singulair® is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older. singulair is indicated for prevention of exercise-induced bronchoconstriction (eib) in patients 6 years of age and older. singulair is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older. because the benefits of singulair may not outweigh the risk of neuropsychiatric symptoms in patients with allergic rhinitis [see warnings and precautions (5.1)] , reserve use for patients who have an inadequate response or intolerance to alternative therapies. singulair is not indicated for the treatment of an acute asthma attack. singulair is contraindicated in patients with hypersensitivity to any of its components. risk summary available data from published prospective and retrospective cohort studies over decades with montelukast use in pregnant women have not estab

Israel - engleză - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - granules - montelukast as sodium 4 mg - montelukast - singulair is indicated in adult and pediatric patients 12 months of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin - sensitive asthmatic patients, and the prevention of exercise - induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma.singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability.

Israel - engleză - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - chewable tablets - montelukast as sodium 5 mg - montelukast - montelukast - singulair 5 mg is indicated in adult and pediatric patients 6 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms of the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. singulair is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.because the benefits of singulair may not outweigh the risk of neuropsychiatric symptoms in patients with seasonal rhinitis [see warnings and precautions (5.1)], reserve use for patients who have an intolerance to alternative therapies.

Israel - engleză - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - tablets - montelukast as sodium 10 mg - montelukast - montelukast - singulair 10 mg is indicated in adult and adolescents 15 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms of the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. singulair is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.because the benefits of singulair may not outweigh the risk of neuropsychiatric symptoms in patients with seasonal rhinitis [see warnings and precautions (5.1)], reserve use for patients who have an intolerance to alternative therapies.

Israel - engleză - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - chewable tablets - montelukast as sodium 4 mg - montelukast - montelukast - singulair is indicated in pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability.singulair is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.because the benefits of singulair may not outweigh the risk of neuropsychiatric symptoms in patients with seasonal rhinitis [see warnings and precautions (5.1)], reserve use for patients who have an intolerance to alternative therapies.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

ulai health llc - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - expectorant cough suppressant - helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus - helps make cough more productive - temporarily relieves cough due to minor throat and bronchial irritation as may occur with a common cold - if you are now taking a prescription monoamine oxidase inhibitor (maoi) (certain drugs for depression, psychiatric or emotional conditions, or parkinson’s disease), or for 2 weeks after stopping the maoi drug. if you do not know whether your prescription drug contains an maoi, ask your doctor or pharmacist before using this product. - persistent or chronic cough, such as occurs with smoking, asthma, chronic bronchitis, or emphysema - cough accompanied by too much phlegm (mucus) - do not use more than directed - cough lasts more than 7 days, comes back, or occurs with fever, rash or persistent headache these could be signs of a serious illness. ask a health professional before use. in case of overdose, get medical help or contact

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

ulai health llc - calcium carbonate (unii: h0g9379fgk) (carbonate ion - unii:7ujq5ope7d, calcium cation - unii:2m83c4r6zb) - antacid for the relief of - acid indigestion - heartburn - sour stomach - upset stomach associated with these symptoms - more than 4 tablets in 24 hours - the maximum dosage for more than two weeks, unless directed by a doctor - kidney stones - a calcium-restricted diet - presently taking a prescription drug. antacids may interact with certain prescription drugs. ask a health professional before use.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

ulai health llc - chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u) - antihistamine - temporarily relieves these following symptoms due to hay fever or other upper respiratory allergies: - runny nose - itchy, watery eyes - sneezing - itching of the nose or throat to make a child sleepy. - glaucoma - a breathing problem such as emphysema or chronic bronchitis - trouble urinating due to an enlarged prostate gland taking sedatives or tranquilizers. - drowsiness may occur - avoid alcoholic drinks - alcohol, sedatives, and tranquilizers may increase drowsiness - use caution when driving a motor vehicle or operating machinery - excitability may occur, especially in children ask a health professional before use. in case of overdose, get medical help or contact a poison control center right away (1-800-222-1222).

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

ulai health llc - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - nighttime sleep aid - helps reduce difficulty falling asleep - in children under 12 years of age - with any other product containing diphenhydramine, even one used on skin - with other antihistamines - glaucoma - a breathing problem such as emphysema or chronic bronchitis - trouble urinating due to an enlarged prostate gland taking sedatives or tranquilizers. - avoid alcoholic drinks - use caution when driving a motor vehicle or operating machinery sleeplessness persists continuously for more than 2 weeks. insomnia may be a symptom of serious underlying medical illness. ask a health professional before use. in case of overdose, get medical help or contact a poison control center right away (1-800-222-1222).

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

merck sharp & dohme corp. - montelukast sodium (unii: u1o3j18sfl) (montelukast - unii:mhm278sd3e) - montelukast 4 mg - singulair® is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older. singulair is indicated for prevention of exercise-induced bronchoconstriction (eib) in patients 6 years of age and older. singulair is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older. because the benefits of singulair may not outweigh the risk of neuropsychiatric symptoms in patients with allergic rhinitis [see warnings and precautions (5.1)] , reserve use for patients who have an inadequate response or intolerance to alternative therapies. singulair is not indicated for the treatment of an acute asthma attack. singulair is contraindicated in patients with hypersensitivity to any of its components. risk summary available data from published prospective and retrospective cohort studies over decades with montelukast use in pregnant women have not estab